Docebo (DCBO) Research & Development (2019 - 2026)

Docebo has reported Research & Development for 8 years, with the latest figure at $15.5 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 15.32% year-over-year to $15.5 million; the trailing twelve-month figure through Mar 2026 stood at $52.2 million (up 11.25% YoY), and the FY2025 full-year result was $50.1 million, up 14.15% from the prior year.
• Research & Development for Q1 2026 stood at $15.5 million, up from $12.1 million in the prior quarter.
• The five-year high for Research & Development was $15.5 million in Q1 2026, with the low at $6.1 million in Q3 2022.
• Historically, Research & Development has averaged $10.0 million across 5 years, with a median of $10.4 million in 2024.
• Annual changes were most pronounced in 2023 — Research & Development soared 68.24% — and 2025, when it increased 4.63%.
• Docebo's Research & Development stood at $6.4 million in 2022, then soared by 41.49% to $9.0 million in 2023, then advanced by 28.31% to $11.6 million in 2024, then grew by 4.63% to $12.1 million in 2025, then grew by 27.61% to $15.5 million in 2026.
• The last three Research & Development figures came in at $15.5 million (Q1 2026), $12.1 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.